Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.563NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.34ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.258ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.258ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.258ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.258NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.426ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.426ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.426ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.426NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.399ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.399ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.399ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.399NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.337ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.337ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.337ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.337NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.539ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.539ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.539ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.539NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.54ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.54ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.54NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.164ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.164ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.164ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.164NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KY.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.392ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.392ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.392ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.392NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.377ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used